Pfizer announced on Monday that it is halting development of its oral weight-loss pill after one patient experienced liver issues. The company said it halted development of danuglipron, an oral drug ...
April 14 (UPI) --Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury and previous problems with other pill versions. The ...
AXIS Capital Holdings Limited (" AXIS Capital" or the "Company") (NYSE: AXS) today announced the publication of the Company's 2021 Loss Development Triangles. A copy of this document is available in ...
PEMBROKE, Bermuda--(BUSINESS WIRE)--Validus Holdings, Ltd. (NYSE:VR) (“Validus”) today announced that it has published its 2017 Loss Development Triangles (the “2017 Triangles”) on its website located ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback